AR

Anand Rajiv Naik

Active Director Designated Partner DIN 11546597
DIN 11546597 First appointment Feb 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Anand Rajiv Naik

Data last updated:

Anand Rajiv Naik is a Designated Partner at Sinhagad Speciality Hospital Llp (since 2026). The company operates in Healthcare.

DIN 11546597
Primary Designation Designated Partner
Industry Healthcare
First Appointment 16 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Feb 2026Active

Board colleagues of Anand Rajiv Naik

NameDINCompanyDesignation
Nitin Narayan Patil09474033Sinhagad Speciality Hospital LlpDesignated Partner
Sumit Suresh Agrawal09474034Sinhagad Speciality Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sinhagad Speciality Hospital Llp
Premium access

Shareholding and investment profile for Anand Rajiv Naik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Rajiv Naik

Anand Rajiv Naik currently holds 1 directorship: Sinhagad Speciality Hospital Llp (Designated Partner, since 16 Feb 2026).

Anand Rajiv Naik was first appointed on 16 Feb 2026 as Designated Partner at Sinhagad Speciality Hospital Llp.

The current boards of Anand Rajiv Naik's companies include Nitin Narayan Patil (Sinhagad Speciality Hospital Llp), Sumit Suresh Agrawal (Sinhagad Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available